Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: Jun 26, 2026, 4:00 PM EDT
1.148
+0.008 (0.67%)
After-hours: Jun 26, 2026, 7:23 PM EDT
Pliant Therapeutics Employees
Pliant Therapeutics had 49 employees as of December 31, 2025. The number of employees decreased by 122 or -71.35% compared to the previous year.
Employees
49
Change (1Y)
-122
Growth (1Y)
-71.35%
Revenue / Employee
n/a
Profits / Employee
-$2,310,571
Market Cap
70.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Seres Therapeutics | 66 |
| BeyondSpring | 44 |
| eXoZymes | 32 |
| Gain Therapeutics | 21 |
| ImageneBio | 17 |
| Edesa Biotech | 17 |
PLRX News
- 5 weeks ago - Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 5 weeks ago - Pliant Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Pliant Therapeutics reports Q1 EPS (32c), consensus (36c) - TheFly
- 6 weeks ago - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Pliant Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Pliant Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Pliant Therapeutics doses first participant in FORTIFY expansion trial - TheFly